| 臺大學術典藏 |
2020-06-17T05:21:30Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
YI-DER JIANG;Chuang L.-M.;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.; YI-DER JIANG; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; Chuang L.-M. |
| 臺大學術典藏 |
2020-06-01T06:57:14Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Tseng F.-Y.;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shyang-Rong Shih;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; Tseng F.-Y.; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; SHYANG-RONG SHIH; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-06-01T04:30:51Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
LEE-MING CHUANG;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.;Jiang Y.-D.; Jiang Y.-D.; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; LEE-MING CHUANG |
| 臺大學術典藏 |
2020-06-01T03:55:31Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Fen-Yu Tseng;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shih S.-R.;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; FEN-YU TSENG; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T03:25:53Z |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Yu-Hsiang Chou;Yen C.-J.;Lai T.-S.;Chen Y.-M.; YU-HSIANG CHOU; Yen C.-J.; Lai T.-S.; Chen Y.-M. |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors
|
Ansell P; Motwani M; Wong S; Yue H; Wang L; Reilly E; Afar D; Naumovski L; Ramanathan R.K.; Strickler J.H; LoRusso P; Salgia R; Kang Y.-K; Yen C.J; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Bogenrieder T; Twelves C; Cheng A.-L.; Huang D.C.-L; Strelkowa N; Goeldner R.-G; Schmid U; Fuertig R; Buschke S; Jove M; Anthoney A; Yen C.-J; de Bono J; Chia-Chi Lin; Chen L.-T; Corral J; Michalarea V; Rihawi K; Ong M; Lee J.-H; Hsu C.-H; Yang J.C.-H; Shiah H.-S |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:09Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Cheng A.-L.; Twelves C.; Bogenrieder T.; Huang D.C.-L.; Strelkowa N.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Shiah H.-S.; Yang J.C.-H.; CHIH-HUNG HSU; Lee J.-H.; de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; De Bono J.;Lin C.-C.;Chen L.-T.;Corral J.;Michalarea V.;Rihawi K.;Ong M.;Lee J.-H.;Chih-Hung Hsu;Yang J.C.-H.;Shiah H.-S.;Yen C.-J.;Anthoney A.;Jove M.;Buschke S.;Fuertig R.;Schmid U.;Goeldner R.-G.;Strelkowa N.;Huang D.C.-L.;Bogenrieder T.;Twelves C.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma
|
Lim H.Y.; Heo J.; Choi H.J.; Lin C.-Y.; Yoon J.-H.; Chiun Hsu; Rau K.-M.; Poon R.T.P.; Yeo W.; Park J.-W.; Tay M.H.; Hsieh W.-S.; Kappeler C.; Rajagopalan P.; Krissel H.; Jeffers M.; Yen C.-J.; Tak W.Y. |
| 臺大學術典藏 |
2020-04-10T12:15:59Z |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Chen Y.-C.; Ohishi N.; O’Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Frenette C.; Lin Z.-Z.; YU-YUN SHAO; Wan P.; Ma J.; Lyashchenko S.K.; Gansukh B.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Abou-Alfa G.K.;Yen C.-J.;Hsu C.-H.;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Yu-Yun Shao;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A. |
| 臺大學術典藏 |
2020-04-10T12:15:58Z |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen W.-C.;Chen J.-S.;Yu-Yun Shao;Lee K.-D.;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Liao Y.-M.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Chou W.-C.;Hsieh R.-K.; Shen W.-C.; Chen J.-S.; YU-YUN SHAO; Lee K.-D.; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Liao Y.-M.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Chou W.-C.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou W.-C.;Chen J.-S.;Hung C.-Y.;Lu C.-H.;Yu-Yun Shao;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Yeh S.-P.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Hsieh R.-K.; Chou W.-C.; Chen J.-S.; Hung C.-Y.; Lu C.-H.; YU-YUN SHAO; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Yeh S.-P.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Hwang W.-L.; Liu T.-C.; Yu M.-S.; Sung Y.-C.; Lee K.-D.; Lai P.-Y.; Hsieh R.-K.; Lee M.-Y.; Chiou T.-J.; Yeh S.-P.; Chen J.-S.; Chang C.-S.; Cho S.-F.;Rau K.-M.;Yu-Yun Shao;Yen C.-J.;Wu M.-F.;Chen J.-S.;Chang C.-S.;Yeh S.-P.;Chiou T.-J.;Hsieh R.-K.;Lee M.-Y.;Sung Y.-C.;Lee K.-D.;Lai P.-Y.;Yu M.-S.;Hwang W.-L.;Liu T.-C.; Cho S.-F.; Rau K.-M.; YU-YUN SHAO; Yen C.-J.; Wu M.-F. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:52Z |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Hwang W.-L.; Chiou T.-J.; Lai P.-Y.; Yen C.-J.; Lin J.; Hsieh R.-K.; Chen J.-S.; Lee K.-D.; Rau K.-M.; YU-YUN SHAO; Sung Y.-C.; Yeh S.-P.; Chang C.-S.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S. |
| 臺大學術典藏 |
2020-03-27T02:03:30Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Lee J.K.; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; Hung K.Y.; Wu C.K.; Fang C.C.; KAO-LANG LIU; Yang C.Y.; Lien Y.C.; Huang J.W.; Huang J.W.;Lien Y.C.;Yang C.Y.;Kao-Lang Liu;Fang C.C.;Wu C.K.;Lee J.K.;Wu H.Y.;Chiang C.K.;Cheng H.T.;Yen C.J.;Hung K.Y. |
| 臺大學術典藏 |
2020-03-27T02:03:28Z |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Hung K.-Y.; Huang J.-W.;Lien Y.-C.;Yang C.-Y.;Kao-Lang Liu;Wu C.-F.;Yen C.-J.;Wu C.-K.;Lee J.-K.;Ho S.-R.;Wu H.-Y.;Chiang C.-K.;Cheng H.-T.;Shyu R.-S.;Hung K.-Y.; Huang J.-W.; Lien Y.-C.; Yang C.-Y.; KAO-LANG LIU; Wu C.-F.; Yen C.-J.; Wu C.-K.; Lee J.-K.; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:18Z |
Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth
|
Tsai T.-J.;Yen C.-J.;Cheng-Chung Fang;Yang C.-C.;Lee P.-H.;Yen T.-S.; Yen T.-S.; Yang C.-C.; Lee P.-H.; CHENG-CHUNG FANG; Tsai T.-J.; Yen C.-J. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Extracellular matrix proteins modulate human peritoneal mesothelial cell behavior
|
Tsai T.-J.; Lee P.-H.; Wu K.-D.; Yen C.-J.;Cheng-Chung Fang;Chen Y.-M.;Lin R.-H.;Wu K.-D.;Lee P.-H.;Tsai T.-J.; Yen C.-J.; CHENG-CHUNG FANG; Chen Y.-M.; Lin R.-H. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis
|
CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Ko F.-N.; Tsai T.-J.; Lee P.-H.; Hsieh B.-S.; Cheng-Chung Fang;Yen C.-J.;Chen Y.-M.;Ko F.-N.;Tsai T.-J.;Lee P.-H.;Hsieh B.-S. |
